Evelyne Gicquel

Title: Evelyne Gicquel: Innovator in Gene Therapy

Introduction

Evelyne Gicquel is a prominent inventor based in Vert-le-Petit, France. She has made significant contributions to the field of gene therapy, particularly through her innovative work on adeno-associated viruses.

Latest Patents

Evelyne Gicquel holds a patent for a hybrid recombinant adeno-associated virus serotype that combines AAV9 and AAVrh74. This invention features a recombinant hybrid AAV capsid protein that exhibits reduced liver tropism compared to its parent serotypes. The hybrid AAV serotype vector particles are designed to package a gene of interest, making them valuable for gene therapy applications, especially in treating neuromuscular genetic diseases.

Career Highlights

Throughout her career, Evelyne has worked with notable organizations such as Genethon and the Institut National de la Santé et de la Recherche Médicale. Her work has been instrumental in advancing the understanding and application of gene therapy techniques.

Collaborations

Evelyne has collaborated with esteemed colleagues, including Isabelle Richard and Federico Mingozzi, contributing to the collective knowledge and innovation in her field.

Conclusion

Evelyne Gicquel's contributions to gene therapy through her innovative patents and collaborations highlight her role as a leading inventor in the medical research community. Her work continues to pave the way for advancements in treating genetic diseases.